Superstring Capital Management LP
- SEC CIK
- 0001931118
- 最新申報
- 2026/8/14
2026 年第 1 季持倉
持倉截至 2026/3/31，2026/5/14 申報。只含多頭部位，變化是跟 2025 年第 4 季比股數。
- 持股檔數
- 35
- 較 2025 年第 4 季 −10
- 總值
- $1.40 億
- 較 2025 年第 4 季 −$4,681 萬 (−25.1%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| SMMTSummit Therapeutics Inc. | COM | 892,873 | $1,693 萬 | 12.1% | +892,873 | 新進 | 歷史 |
| IMVTImmunovant, Inc. | COM | 357,606 | $888.3 萬 | 6.3% | +68,929+23.9% | 加碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 225,158 | $866.6 萬 | 6.2% | −141,080−38.5% | 減碼 | 歷史 |
| SVRASavara Inc | COM | 1,585,977 | $865.9 萬 | 6.2% | +590,624+59.3% | 加碼 | 歷史 |
| URGNUroGen Pharma Ltd. | COM | 387,371 | $696.5 萬 | 5.0% | −330,983−46.1% | 減碼 | 歷史 |
| DFTXDefinium Therapeutics, Inc. | COM SHS | 351,461 | $664.3 萬 | 4.7% | −73,741−17.3% | 減碼 | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 730,548 | $654.6 萬 | 4.7% | +730,548 | 新進 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 110,454 | $641.8 萬 | 4.6% | +110,454 | 新進 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 180,048 | $571.1 萬 | 4.1% | +91,740+103.9% | 加碼 | 歷史 |
| SIONSionna Therapeutics, Inc. | COM | 141,024 | $565.4 萬 | 4.0% | −39,569−21.9% | 減碼 | 歷史 |
| GMABGenmab A/S | SPONSORED ADS | 196,709 | $527.8 萬 | 3.8% | +167,547+574.5% | 加碼 | 歷史 |
| ZLABZai Lab Ltd | ADR | 275,818 | $518.8 萬 | 3.7% | +78,965+40.1% | 加碼 | 歷史 |
| VRTXVertex Pharmaceuticals Inc | Stock | 11,010 | $491.6 萬 | 3.5% | +11,010 | 新進 | 歷史 |
| IQVIQVIA Holdings Inc. | Stock | 25,668 | $437.7 萬 | 3.1% | +25,668 | 新進 | 歷史 |
| MPLTMapLight Therapeutics, Inc. | COM | 192,139 | $390.6 萬 | 2.8% | +192,139 | 新進 | 歷史 |
| ARVNArvinas, Inc. | COM | 312,620 | $331.4 萬 | 2.4% | +312,620 | 新進 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 63,591 | $311.9 萬 | 2.2% | +63,591 | 新進 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 5,186 | $307.5 萬 | 2.2% | −4,265−45.1% | 減碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 102,754 | $305.3 萬 | 2.2% | +64,732+170.2% | 加碼 | 歷史 |
| TRVITrevi Therapeutics, Inc. | COM | 251,566 | $300.1 萬 | 2.1% | +103,274+69.6% | 加碼 | 歷史 |
| ANLAdlai Nortye Group Ltd. | ADS | 414,852 | $287.1 萬 | 2.1% | +414,852 | 新進 | 歷史 |
| CABACabaletta Bio, Inc. | COM | 1,066,239 | $286.8 萬 | 2.0% | −1,187,311−52.7% | 減碼 | 歷史 |
| PFEPfizer Inc | Stock | 74,000 | $207.8 萬 | 1.5% | +74,000 | 新進 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 11,217 | $189.6 萬 | 1.4% | −26,216−70.0% | 減碼 | 歷史 |
| ORICOric Pharmaceuticals, Inc. | COM | 115,234 | $146.0 萬 | 1.0% | −140,136−54.9% | 減碼 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 366,490 | $137.4 萬 | 1.0% | +366,490 | 新進 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 199,209 | $136.5 萬 | 1.0% | +199,209 | 新進 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 258,269 | $115.4 萬 | 0.8% | −722,499−73.7% | 減碼 | 歷史 |
| DRUGBright Minds Biosciences Inc. | COM NEW | 13,311 | $97.1 萬 | 0.7% | −33,967−71.8% | 減碼 | 歷史 |
| TNXPTonix Pharmaceuticals Holding Corp. | COM NEW | 63,540 | $87.4 萬 | 0.6% | +63,540 | 新進 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 59,484 | $84.5 萬 | 0.6% | +59,484 | 新進 | 歷史 |
| TARAProtara Therapeutics, Inc. | COM STK | 121,457 | $63.3 萬 | 0.5% | −238,543−66.3% | 減碼 | 歷史 |
| PTNPalatin Technologies Inc | COM NEW | 35,969 | $62.7 萬 | 0.4% | +1,998+5.9% | 加碼 | 歷史 |
| BMEABiomea Fusion, Inc. | COM | 250,000 | $38.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 119,308 | $27.0 萬 | 0.2% | −343,655−74.2% | 減碼 | 歷史 |
2025 年第 4 季之後清倉（24 檔）
2025 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 4 季股數 | 2025 年第 4 季市值 | 2025 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| CDTXCidara Therapeutics, Inc. | COM NEW | 85,098 | $1,880 萬 | 10.1% | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 443,777 | $1,793 萬 | 9.6% | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 525,592 | $808.4 萬 | 4.3% | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 418,080 | $507.5 萬 | 2.7% | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 352,896 | $502.5 萬 | 2.7% | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 54,879 | $437.1 萬 | 2.3% | 歷史 |
| BLTEBelite Bio, Inc | SPONSORED ADS | 24,703 | $395.1 萬 | 2.1% | 歷史 |
| ZBIOZenas BioPharma, Inc. | COM | 83,353 | $302.7 萬 | 1.6% | 歷史 |
| QNCXQuince Therapeutics, Inc. | COM | 858,711 | $287.7 萬 | 1.5% | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 153,313 | $278.4 萬 | 1.5% | 歷史 |
| CAPRCapricor Therapeutics, Inc. | COM NEW | 96,334 | $278.0 萬 | 1.5% | 歷史 |
| PVLAPalvella Therapeutics, Inc. | COM | 25,469 | $266.6 萬 | 1.4% | 歷史 |
| ASMBAssembly Biosciences, Inc. | COM NEW | 65,273 | $222.0 萬 | 1.2% | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 58,677 | $154.3 萬 | 0.8% | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 43,230 | $134.5 萬 | 0.7% | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 513,765 | $121.2 萬 | 0.6% | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 26,249 | $108.2 萬 | 0.6% | 歷史 |
| SPRBSpruce Biosciences, Inc. | COM NEW | 12,137 | $105.7 萬 | 0.6% | 歷史 |
| AARDAardvark Therapeutics, Inc. | COM | 69,496 | $91.2 萬 | 0.5% | 歷史 |
| PALIPalisade Bio, Inc. | COM | 367,103 | $86.3 萬 | 0.5% | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 72,060 | $81.5 萬 | 0.4% | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 31,738 | $73.0 萬 | 0.4% | 歷史 |
| IVAInventiva S.A. | ADS | 100,000 | $46.5 萬 | 0.2% | 歷史 |
| ENTXEntera Bio Ltd. | SHS | 17,142 | $3.33 萬 | <0.1% | 歷史 |